Bottneuro AG
PrivateLast Round
Grant
Apr 8, 2026
Total Funding Raised
$160,000
Company Overview
Bottneuro AG is a neurotech company that develops non-invasive, personalized neuromodulation therapies and diagnostic solutions for patients with neurological conditions such as Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bottneuro AG Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Bottneuro AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 8, 2026 | ||||
| VC Round | Dec 15, 2022 | ||||
| Grant | Dec 17, 2021 | ||||
| Seed | Nov 1, 2021 |
Bottneuro AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kickfund | Seed |
| DART Ventures | VC Round |
| Venture Kick | Grant |
| Innosuisse | Grant |
Bottneuro AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bottneuro AG's valuation, stock price, and market status.